New Leaf Biopharma Opportunities I, L.p. - Net Worth and Insider Trading
New Leaf Biopharma Opportunities I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Leaf Biopharma Opportunities I, L.p. owns 2 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , and Aptinyx Inc (APTX) .
Insider Ownership Summary of New Leaf Biopharma Opportunities I, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2017-09-27 | 10 percent owner |
| APTX | Aptinyx Inc | 2018-06-20 | 10 percent owner |
New Leaf Biopharma Opportunities I, L.p. Trading Performance
New Leaf Biopharma Opportunities I, L.p. Ownership Network
New Leaf Biopharma Opportunities I, L.p. Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
New Leaf Biopharma Opportunities I, L.p. is the 10 percent owner of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, New Leaf Biopharma Opportunities I, L.p. made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 112,502 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 21,000 shares were bought by its insiders, resulting in a net sale of 91,502 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
New Leaf Biopharma Opportunities I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for New Leaf Biopharma Opportunities I, L.p.. You might contact New Leaf Biopharma Opportunities I, L.p. via mailing address: C/o New Leaf Venture Partners, 7 Times Square, Suite 3502, New York Ny 10036.
Discussions on New Leaf Biopharma Opportunities I, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
